LOOMIS SAYLES & CO L P - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$4,764,000
-44.4%
115,839
-47.7%
0.01%
-44.4%
Q1 2018$8,566,000
-25.1%
221,457
-30.2%
0.02%
-25.0%
Q4 2017$11,433,000
+205.4%
317,206
+66.9%
0.02%
+166.7%
Q2 2017$3,744,000190,0900.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
SYMPHONY ASSET MANAGEMENT LLC 23,872,000$18,748,0004.04%
PFM Health Sciences, LP 49,764,825$39,319,0001.16%
Partner Investment Management, L.P. 659,175$521,0000.89%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 40,000,000$31,402,000,0000.87%
Bruce & Co., Inc. 6,000,000$4,200,0000.87%
CANYON CAPITAL ADVISORS LLC 36,500,000$28,747,0000.62%
PenderFund Capital Management Ltd. 2,000,000$1,571,0000.53%
Shaolin Capital Management LLC 4,000,000$3,136,0000.48%
Castle Creek Arbitrage, LLC 2,310,000$1,815,0000.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,500,000$4,368,0000.27%
View complete list of ACORDA THERAPEUTICS INC shareholders